Cargando…

Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response

Mostrar otras versiones (1)

Understanding the molecular features of neutralizing epitopes is important for developing vaccines/therapeutics against emerging SARS-CoV-2 variants. We describe three monoclonal antibodies (mAbs) generated from COVID-19 recovered individuals during the first wave of the pandemic in India. These mAb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Anamika, Kumar, Sanjeev, Lai, Lilin, Chakravarthy, Chennareddy, Valanparambil, Rajesh, Reddy, Elluri Seetharami, Gottimukkala, Kamalvishnu, Bajpai, Prashant, Raju, Dinesh Ravindra, Edara, Venkata Viswanadh, Davis-Gardner, Meredith E., Linderman, Susanne, Dixit, Kritika, Sharma, Pragati, Mantus, Grace, Cheedarla, Narayanaiah, Verkerke, Hans P., Frank, Filipp, Neish, Andrew S., Roback, John D., Davis, Carl W., Wrammert, Jens, Ahmed, Rafi, Suthar, Mehul S., Sharma, Amit, Murali-Krishna, Kaja, Chandele, Anmol, Ortlund, Eric A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171968/ https://www.ncbi.nlm.nih.gov/pubmed/37167972 http://dx.doi.org/10.1016/j.str.2023.04.010

Ejemplares similares

Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response
por: Patel, Anamika, et al.
Publicado: (2022)

Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody
por: Kumar, Sanjeev, et al.
Publicado: (2022)

Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India
por: Nayak, Kaustuv, et al.
Publicado: (2021)

Optimization of Flow-Cytometry Based Assay for Measuring Neutralizing Antibody Responses against Each of the Four Dengue Virus Serotypes
por: Sharma, Pragati, et al.
Publicado: (2021)

COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood
por: Govindaraj, Sakthivel, et al.
Publicado: (2023)

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma
por: Nooka, Ajay K., et al.
Publicado: (2022)

Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination
por: Mantus, Grace, et al.
Publicado: (2022)

Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2021)

Correction: Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2022)

Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection
por: Lapp, Stacey A., et al.
Publicado: (2021)

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant
por: Edara, Venkata-Viswanadh, et al.
Publicado: (2022)

Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January–March 2021
por: Graciaa, Daniel S., et al.
Publicado: (2022)

SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
por: Routhu, Nanda Kishore, et al.
Publicado: (2021)

PATIENTS WITH ASTHMA OR ATOPIC DERMATITIS TAKING BIOLOGIC THERAPIES HAVE REDUCED SARS-COV-2 VACCINE RESPONSE AT SIX MONTHS
por: RUNNSTROM, MARTIN C, et al.
Publicado: (2022)

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells
por: Cohen, Kristen W., et al.
Publicado: (2021)

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells
por: Cohen, Kristen W., et al.
Publicado: (2021)

Profiles of host immune impairment in Plasmodium and SARS-CoV-2 infections
por: Chaturvedi, Rini, et al.
Publicado: (2022)

Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment
por: Faliti, Caterina E., et al.
Publicado: (2023)

Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers
por: Cheedarla, Narayanaiah, et al.
Publicado: (2023)

Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
por: Suthar, Mehul S., et al.
Publicado: (2020)

Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults
por: Joshi, Devyani, et al.
Publicado: (2023)

Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India
por: Chandele, Anmol, et al.
Publicado: (2016)

Structural Profiles of SARS-CoV-2 Variants in India
por: Chakraborti, Soumyananda, et al.
Publicado: (2022)

321 Prevalence of SARS-CoV-2 Antibodies in Pediatric Health Care Workers in Atlanta, Georgia
por: Morris, C.R., et al.
Publicado: (2020)

Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimers
por: Cheedarla, Narayanaiah, et al.
Publicado: (2022)

Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
por: Edara, Venkata Viswanadh, et al.
Publicado: (2021)

371. Estimating SARS-CoV-2 Seroprevalence from Spent Blood Samples, January–March 2021
por: Graciaa, Daniel, et al.
Publicado: (2021)

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
por: Routhu, Nanda Kishore, et al.
Publicado: (2021)

Global Regulator SATB1 Recruits β-Catenin and Regulates T(H)2 Differentiation in Wnt-Dependent Manner
por: Notani, Dimple, et al.
Publicado: (2010)

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
por: Hurlburt, Nicholas K., et al.
Publicado: (2020)

Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses
por: Bajpai, Prashant, et al.
Publicado: (2022)

Impact of COVID-19 Vaccination on Pregnant Women
por: Chaubey, Ishaan, et al.
Publicado: (2023)

Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection
por: Damhorst, Gregory L, et al.
Publicado: (2023)

Blood Group A Enhances SARS-CoV-2 Infection
por: Wu, Shang-Chuen, et al.
Publicado: (2022)

Blood Group A Enhances SARS-CoV-2 Infection
por: Wu, Shang-Chuen, et al.
Publicado: (2023)

Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
por: Edara, Venkata-Viswanadh, et al.
Publicado: (2021)

β-Catenin Regulates Wound Healing and IL-6 Expression in Activated Human Astrocytes
por: Edara, Venkata Viswanadh, et al.
Publicado: (2020)

Activated human astrocyte-derived extracellular vesicles modulate neuronal uptake, differentiation and firing
por: You, Yang, et al.
Publicado: (2019)

Dynamic regulation of chromatin organizer SATB1 via TCR-induced alternative promoter switch during T-cell development
por: Patta, Indumathi, et al.
Publicado: (2020)

Poster: CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
por: Chang, Andres, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_40ck676nrcmnvl9vsmepcd6fue